Compass Therapeutics, Inc. Stock
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.820 USD | -4.21% |
|
-9.00% | -66.11% |
| Market Cap | 342M 298M 281M 256M 480M 32.78B 481M 3.37B 1.3B 16.7B 1.29B 1.26B 53.84B | P/E 2026 * |
-3.79x | P/E 2027 * | -3.44x |
|---|---|---|---|---|---|
| Enterprise Value | 192M 168M 158M 144M 270M 18.41B 270M 1.89B 728M 9.38B 722M 706M 30.24B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.34x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Last Transcript: Compass Therapeutics, Inc.
| 1 week | -9.00% | ||
| Current month | -23.85% | ||
| 1 month | -22.88% | ||
| 3 months | -9.90% | ||
| 6 months | -64.66% | ||
| Current year | -66.11% |
| 1 week | 1.8 |  | 1.98 |
| 1 month | 1.8 | | 2.55 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 2024-05-27 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 2024-12-08 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 2013-12-31 |
Phil Ferneau
BRD | Director/Board Member | 64 | 2014-12-31 |
Carl Gordon
CHM | Chairman | 61 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/29/26 | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 4/29/26 | Buy | General Counsel | 25,000 | 0.0139% | ||
| 4/29/26 | Free | Controller/Auditor | 15,000 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.21% | -9.00% | -46.31% | -5.21% | 342M | |
| +4.98% | +11.06% | +54.45% | +109.45% | 70.88B | |
| -0.39% | +1.66% | +38.84% | +78.01% | 62.49B | |
| +5.26% | +12.77% | +40.29% | +26.34% | 26.34B | |
| +0.83% | -6.50% | -16.41% | +374.14% | 26.21B | |
| +2.02% | +1.31% | +1.85% | -9.77% | 24.13B | |
| 0.00% | +8.03% | +25.03% | -13.74% | 20.72B | |
| -2.54% | -10.16% | +149.64% | +313.93% | 15.69B | |
| -1.95% | +1.96% | +42.69% | +166.02% | 14.46B | |
| -5.32% | -3.70% | -10.53% | +808.60% | 14.24B | |
| Average | +0.29% | +1.26% | +27.95% | +184.78% | 27.55B | |
| Weighted average by Cap. | +1.43% | +2.89% | +37.31% | +150.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 22.39M 19.53M 18.38M 16.75M 31.42M 2.15B 31.45M 220M 84.81M 1.09B 84.11M 82.25M 3.52B |
| Net income | -94.04M -82.03M -77.2M -70.35M -132M -9.01B -132M -925M -356M -4.59B -353M -345M -14.8B | -110M -95.8M -90.16M -82.15M -154M -10.52B -154M -1.08B -416M -5.36B -413M -403M -17.28B |
| Net Debt | -150M -131M -123M -112M -210M -14.37B -211M -1.48B -568M -7.32B -563M -551M -23.6B | -133M -116M -109M -99.49M -187M -12.74B -187M -1.31B -504M -6.49B -500M -488M -20.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-21 | US$1.820 | -4.21% | 2,970,237 |
| 26-09-18 | US$1.900 | +2.70% | 8,210,036 |
| 26-09-17 | US$1.850 | +1.09% | 2,515,917 |
| 26-09-16 | US$1.830 | -1.08% | 2,242,999 |
| 26-09-15 | US$1.850 | -5.61% | 2,440,059 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
